# Hera Health Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hera-health-solutions

- Industry: Biotechnology
- Headquarters: Memphis, US
- Website: www.herahealthsolutions.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Nov 5, 2019)
- Investors on record: 1

## About

Hera Health Solutions Inc. specializes in the development of innovative long-acting treatments, utilizing proprietary bioerodible drug delivery implants to enhance contraceptive options for women.Founded in 2017 and headquartered in Memphis, US, Hera Health Solutions Inc. focuses on advancing women's health through innovative medical technology. The company raised USD 1.25 million in Seed funding on November 5, 2019, led by Innova Memphis. Idicula Mathew serves as both the Founder and CEO, bringing experience from previous entrepreneurial ventures.Hera Health Solutions Inc. is primarily focused on the research, development, and commercialization of long-acting treatments through its proprietary bioerodible drug delivery implants. The company's flagship product, Eucontra™, is a biodegradable contraceptive arm implant designed to release a generic contraceptive hormone over time, thus eliminating the need for painful and costly removal procedures associated with traditional implants. This innovative technology aims to provide a safe and effective contraceptive solution for women, addressing gaps in current offerings in the family planning market. The company targets a wide range of end users, including healthcare providers and women seeking long-term contraception solutions, primarily in North America and Europe.While specific revenue figures for Hera Health Solutions Inc. are not publicly disclosed, the company engages in transactions through partnerships with healthcare providers and distributors. The sales model focuses on business-to-business (B2B) engagements, wherein healthcare organizations may purchase the Eucontra™ implant for patient distribution. This model facilitates access to the product for end users while ensuring that healthcare providers are equipped to offer innovative contraceptive solutions. The revenue structure potentially includes arrangements for bulk purchases, fostering partnerships with clinics and hospitals that serve populations interested in long-acting contraceptive methods.Hera Health Solutions Inc. plans to utilize the recent Seed funding of USD 1.25 million, raised in November 2019, to further develop its innovative product offerings. The company is focused on expanding its market presence in North America and Europe, targeting healthcare providers and institutions for distribution. Future product launches will include enhancements to the Eucontra™ line, aimed at providing advanced long-acting contraceptive solutions for women.

## Funding rounds

- Seed, Nov 5, 2019, $1.3M — Innova Memphis
- Seed, May 15, 2018 — Innova Memphis

## Investors

- Innova Memphis (https://capitalatlas.ai/funds/innova-memphis) — Seed